Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.30 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.30 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL9788186 | 0.98 | EPHX1 (0.41) | EPHX1KDM4EGAA | |
| SCHEMBL9788179 | 0.88 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL2512663 | 0.87 | EPHX1 (0.48) | EPHX1KCNA4KCNA1KCNAB1 | |
| SCHEMBL11912902 | 0.85 | EPHX1 (0.38) | EPHX1KCNA4KCNA1KCNAB1 | |
| SCHEMBL4973274 | 0.84 | EPHX1 (0.41) | EPHX1KDM4EGAA | |
| SCHEMBL3055292 | 0.84 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL5161498 | 0.83 | EPHX1 (0.39) | EPHX1KDM4EGAA | |
| SCHEMBL8327277 | 0.82 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL9619313 | 0.82 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL4815468 | 0.81 | EPHX1 (0.37) | EPHX1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105751-A | Synthesis method of ditrimethylolpropane | 武汉埃迪鑫新材料科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-101239966-B | Method for preparing annular aliphatic carbonic ester containing cinnamoyloxy group and polymers thereof | CHANGCHUN APPLIED CHEMISTRY | 2010-05-26 | — | — | CN | claimed |
| US-7416867-B2 | Enzymatic production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-26 | — | — | US | claimed |
| CN-101239966-A | Method for preparing annular aliphatic carbonic ester containing cinnamoyloxy group and polymers thereof | CHANGCHUN APPLIED CHEMISTRY (CN) | 2008-08-13 | — | — | CN | claimed |
| EP-1599594-B1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2007-05-30 | — | — | EP | claimed |
| US-20060141593-A1 | Enzymatic production of (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-29 | — | — | US | claimed |
| EP-1599594-A1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-30 | — | — | EP | claimed |
| WO-2004076676-A1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-10 | — | — | WO | claimed |
| EP-0043966-B1 | PROCESS FOR PREPARING POLYETHERS IN WHICH ARE RETAINED AT LEAST TWO FREE HYDROXYL GROUPS OF THE STARTING ALCOHOLS | Th. Goldschmidt AG (DE) | 1983-12-28 | — | — | EP | claimed |
| EP-0043966-A1 | Process for preparing polyethers in which are retained at least two free hydroxyl groups of the starting alcohols | Th. Goldschmidt AG (DE) | 1982-01-20 | — | — | EP | claimed |
| US-12630665-B2 | Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same | I-SENS, INC. (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4004075-B1 | AQUEOUS CATIONIC POLYURETHANE DISPERSIONS | AGFA NV (BE) | 2026-03-11 | — | — | EP | disclosed |
| US-12497481-B2 | Aqueous cationic polyurethane dispersions | AGFA NV (BE) | 2025-12-16 | — | — | US | disclosed |
| US-12351676-B2 | Non-mixed amphiphilic thermoplastic polyurethane, method for producing same, and implantable medical device including same | I-SENS, INC. (KR) | 2025-07-08 | — | — | US | disclosed |
| US-12180375-B2 | Aqueous cationic polyurethane dispersions | AGFA NV (BE) | 2024-12-31 | — | — | US | disclosed |
| EP-0060430-A2 | Method for the preparation of polymers containing polyoxyalkylene side chains | Th. Goldschmidt AG (DE) | 1982-09-22 | — | — | EP | disclosed |
| EP-0055818-A1 | Process for the production of block polymers containing at least three polyoxyalkylene blocks | Th. Goldschmidt AG (DE) | 1982-07-14 | — | — | EP | disclosed |
| EP-0043966-A1 | Process for preparing polyethers in which are retained at least two free hydroxyl groups of the starting alcohols | Th. Goldschmidt AG (DE) | 1982-01-20 | — | — | EP | disclosed |
| EP-0042505-A2 | Process for the production of polymers with at least one terminal primary hydroxyl group | Th. Goldschmidt AG (DE) | 1981-12-30 | — | — | EP | disclosed |
| US-4250313-A | HEATING A 2,2,6,6-TETRAMETHYL-4-PIPERIDONE AND A 5-METHYLOL-1,3-DIOXANE | ARGUS CHEMICAL CORP. (US) | 1981-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630665-B2 | Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same | PGD, TAF1, HPGDS | EPHX1 1256/4885KDM4E 706/4885GAA 2741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.